The CIDP conundrum: Tackling diagnostic challenges

Episode 2. Luis Querol and Mark Stettner address the challenges of CIDP misdiagnosis, from common mimics to borderline cases where diagnostic criteria alone may be insufficient. Their conversation outlines approaches to minimizing overtreatment, practical strategies for tapering or withdrawing therapy, and how emerging options, including FcRn inhibitors, can be integrated into real-world care.